Drug Trial Radar · NCT00749450
Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer
Last checked: Nov 19, 2026Latest source record: Jul 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
6,088
Actual
Start
Mar 2008
Primary completion
Nov 2017
Sponsor
- Lead sponsor
- Cancer Research UK, GlasgowAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 9, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 120 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, fluorouracil, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known which combination chemotherapy regimen is more effective in treating patients who have undergone surgery for high-risk colorectal cancer. PURPOSE: This randomized phase III trial is studying chemotherapy given after surgery in treating patients with high-risk stage II or stage III colorectal cancer.
Conditions
- Colorectal Cancer
Interventions
capecitabineDrug
Given orally
fluorouracilDrug
Given IV
oxaliplatinDrug
Given IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- 3-year disease-free survivalTime frame: 3 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Beatson West of Scotland Cancer Centre
Glasgow, Scotland, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.